Press Releases

Date Title and Summary
Toggle Summary Accuray's General Counsel Wins Best Bay Area Corporate Counsel Award
Silicon Valley/San Jose Business Journal Names Accuray's Darren Milliken Best General Counsel for a Small Public Company SUNNYVALE, Calif., Feb. 25, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its Senior
Toggle Summary Accuray's Treatment Planning Service Active at 20 Percent of U.S. CyberKnife Centers
Service Offers Specialized Physicist Support to New and Existing CyberKnife Sites SUNNYVALE, Calif. , Oct. 27 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that 20 percent of the company's U.S.
Toggle Summary Accuray's Xsight(TM) Lung Tracking System Gains Clinical Acceptance as U.S. Adoption Rate Exceeds 97 Percent
Monte Carlo Dose Calculation Extends CyberKnife(R) System's Capabilities in Precision Radiation Delivery for Lung Tumors SUNNYVALE, Calif., July 23 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Accuray's Xsight(TM)
Toggle Summary Addenbrooke's Hospital is First in the UK to Treat Cancer Patients with Accuray Radixact® System
Internationally Renowned Centre in Cambridge, England is First NHS Hospital to Install the Innovative Radiation Therapy System SUNNYVALE, Calif. , July 25, 2018 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that the Addenbrooke's Hospital clinical team has treated the first
Toggle Summary Anne B. Le Grand Joins Accuray Board of Directors
SUNNYVALE, Calif. , July 22, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Anne B. Le Grand to the company's Board of Directors, effective as of July 16, 2020 . In addition, she will serve on the Board's Nominating and Corporate Governance Committee .
Toggle Summary Anova Cancer Care Treats 1,000th Prostate Cancer Patient with the CyberKnife® System
Innovative System Provides Extremely Precise, Non-invasive Treatment in Four to Five Sessions SUNNYVALE, Calif. , Oct. 13, 2015 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that Anova Cancer Care in Denver, Colorado , has treated its 1,000th prostate cancer patient with the
Toggle Summary Anova Marks 1,500th Prostate Cancer Patient Treated with the Accuray CyberKnife® System
- Accuray and Anova Cancer Care Remember Prostate Patients this Father's Day - CyberKnife System Provides Grandfathers, Fathers, Brothers, Uncles and Sons with Precise Radiation Treatments in Fewer Treatment Sessions than Conventional Radiation Therapy SUNNYVALE, Calif.
Toggle Summary Apollo Hospitals in India to Acquire Two Accuray Radixact® Systems
New Systems Will Improve the Treatment Process Workflow, Enabling Clinicians to Treat More Patients Every Day SUNNYVALE, Calif. , March 28, 2018 /PRNewswire/ -- Personalized, precise, radiation treatments will soon be available to more cancer patients in India .
Toggle Summary Beloved Family Pet's Lung Cancer is Treated with Targeted Radiotherapy Using the Accuray Radixact® System with Synchrony® Technology
- UW-Madison School of Veterinary Medicine performed the first-in-world treatment - Renowned veterinary school leveraged the advanced Radixact and Synchrony technology, currently available at top academic hospitals, to provide the highest level of care SUNNYVALE, Calif.
Toggle Summary Benefits of CyberKnife Radiosurgery for Lung Cancer Drive Continued Adoption
Patient Experience Demonstrates Precision, Convenience and Quality of Life SUNNYVALE, Calif., Feb 05, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that more than 12,000 courses of lung cancer treatment have been

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.